JP2022149767A - Enhancer for expression of epidermal moisturizing factor or barrier function factor - Google Patents

Abstract

To provide an enhancer for the expression of epidermal moisturizing factors or barrier function factors.SOLUTION: An enhancer for the expression of epidermal moisturizing factors or barrier function factors contains an extract from the bark of Albizia julibrissin.SELECTED DRAWING: None

Description

Disclosed is a technique related to an expression-enhancing agent for an epidermal moisturizing factor or barrier function factor.

Silk tree is a deciduous tall tree of the leguminous family that grows naturally in sunny wetlands such as the forest edges of the mountains south of the Tohoku region and the plains in Japan. Overseas, it is distributed and cultivated in China, Southeast Asia, etc. The bark is collected around the time of flowering, washed with water, dried in the sun, and chopped into appropriate lengths. It has been used externally for swelling, bruises, and arthralgia as a cold poultice on the affected area with a decoction, or as a bathing agent. Silk tree bark is known to contain triterpene saponins (many juribrosides), flavonoids (geraldone, isoochanin, luteolin, etc.), tannins, and the like (Non-Patent Document 1).

As a use of the silk tree extract, for example, it is known to be used for skin cells that exhibit an irregular or abnormal clock gene expression rhythm compared to the normal clock gene expression rhythm (patent Reference 1).

WO2021/005941

Japanese herbal medicine No. 759 (2016.8)

The main object of the present invention is to provide an agent for enhancing the expression of an epidermal moisturizing factor or a barrier function factor.

The present inventors have made intensive studies to solve the above problems, and as a result, found that the extract of the bark of the silk tree can enhance the expression of moisturizing factor or barrier function factor of the epidermis as a new use of the extract of the bark of the silk tree. Based on such knowledge, further research was repeated, and the present invention was completed.

The present invention includes the following aspects.
Section 1.
An agent for enhancing the expression of an epidermal moisturizing factor or a barrier function factor, containing a silk tree bark extract.
Section 2.
Item 2. The expression enhancer according to Item 1, wherein the moisturizing factor or barrier function factor is an epidermal tight junction-related factor, an epidermal differentiation-related factor, or an aquaporin.
Item 3.
Item 1 or wherein the moisturizing factor or barrier function factor is selected from the group consisting of claudin 1, desmocollin 1, integrin 2, filaggrin, keratin 1, keratin 5, keratin 10, keratin 14, loricrin, and aquaporin 3 2. The expression enhancer according to 2.
Section 4.
A composition for preventing or treating a disease or condition associated with decreased expression of epidermal moisturizing factors or barrier function factors, the composition comprising an extract of Albizia bark.
Item 5.
Item 5, wherein the disease or condition is selected from the group consisting of skin aging symptoms, atopic dermatitis, contact dermatitis, psoriasis, ichthyosis, xerosis, acne, allergic rhinitis, and asthma. composition.

According to the present invention, an agent for enhancing the expression of an epidermal moisturizing factor or barrier function factor is provided.

FIG. 10 is a diagram showing increased expression of epidermal tight junction-related genes when Genemclock (trademark) (manufactured by Toyobo Co., Ltd.) is applied to a three-dimensional cultured epidermis model. FIG. 10 is a diagram showing an increase in expression of epidermal differentiation-related genes when Genemclock (trademark) (manufactured by Toyobo Co., Ltd.) is applied to a three-dimensional cultured epidermis model. FIG. 10 shows an increase in the expression of aquaporins when Genemclock (trademark) (manufactured by Toyobo Co., Ltd.) is applied to a three-dimensional cultured epidermis model.

Silk tree bark extract The silk tree bark extract is not limited to being extracted only from the bark of a plant of the genus Silk, as long as it contains the bark, even if it is extracted from the whole or a part thereof (e.g., branches and leaves). good. The Albizia genus plant to be subjected to extraction may be cut as it is, or may be pretreated by drying, pulverization, or the like. In one embodiment, the silk tree bark extract is preferably obtained by extracting the branches and leaves of the silk tree genus plant raw or after drying and pulverizing as necessary.

The extraction solvent is not particularly limited, and examples thereof include water and organic solvents. Specific examples of organic solvents include alcohols such as methanol, ethanol, propanol and butanol; polyhydric alcohols such as propylene glycol and butylene glycol; ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate. Chain and cyclic ethers such as tetrahydrofuran and diethyl ether; Polyethers such as polyethylene glycol; Hydrocarbons such as hexane, cyclohexane and petroleum ether; Aromatic hydrocarbons such as benzene and toluene; , waxes, and other oils. An extraction solvent can be used individually by 1 type or in combination of 2 or more types. When two or more extraction solvents are combined, extraction with a mixed solvent in which two or more extraction solvents are mixed may be used, or a combination of extractions with each extraction solvent (for example, a combination of water extraction and organic solvent extraction). There may be. The extraction solvent is preferably water, alcohols, or a mixed solvent thereof, and more preferably water (especially hot water at 70 to 100°C).

The extraction conditions vary depending on the solvent used. For example, when extracting with water, 1 to 100 parts by weight of water is used per 1 part by weight of silk tree bark, and the temperature is 4 to 100 ° C. for 10 minutes to 7 days. More preferably, the extraction is carried out using 5 to 20 parts by mass of water per 1 part by mass of silk tree bark at a temperature of 70 to 100° C. for 30 minutes to 2 hours. In the case of hot water extraction, the extraction is typically performed under heating and reflux. In addition, from the viewpoint of further increasing the extraction efficiency, pressurization, stirring, ultrasonic treatment, etc. may be performed during the extraction.

The silk tree bark extract may be extracted as it is, or may be subjected to post-treatments such as dilution, concentration, drying, separation, and purification after extraction. Separation methods include, for example, filtration and centrifugation. Purification methods include, for example, fractional extraction, partition between two solvents, fractional adsorption with an adsorbent, elution, chromatography, and the like.

The silk tree bark extract may be in any form, for example, it may be in a solid form such as dry powder (including those subjected to processing such as pulverization after drying), extract liquid, dispersion liquid of dry powder Alternatively, it may be in the form of a liquid such as a solution, or in the form of a paste.

Silk tree bark extract can be prepared, for example, by the method described in JP-A-2018-58783.

Epidermal moisturizing factor or barrier function factor The moisturizing factor or barrier function factor is not particularly limited as long as it exists in the epidermis. The moisturizing factor or barrier function factor may be present in any of the stratum corneum, stratum granulosum, stratum spinosum, and stratum basale, which constitute the surface layer. In one embodiment, the epidermal moisturizing factor or barrier function factor may be, for example, an epidermal tight junction-related factor, an epidermal differentiation-related factor, or the like. claudin (e.g., claudin 1), desmocolin (e.g., desmocolin 1), integrin (e.g., integrin 2), profilaggrin, filaggrin, loricrin, involucrin, transglutaminase, keratin (e.g., keratin 1, keratin 5, keratin 10, keratin 14), aquaporin (eg, aquaporin 3), and the like. Among these, one selected from the group consisting of claudin 1, desmocollin 1, integrin 2, filaggrin, loricrin, keratin 1, keratin 5, keratin 10, keratin 14, and aquaporin 3 is preferred.

Expression-Enhancing Agents Expression-enhancing agents enhance the expression of moisturizing factors or barrier function factors in the epidermis when applied to the epidermis compared to when the expression-enhancing agent is not applied to the epidermis. As long as there is no particular limitation. The degree of enhancement of expression is not particularly limited as long as the expression level when the expression-enhancing agent is applied to the epidermis exceeds 1-fold the expression level when the expression-enhancing agent is not applied to the epidermis. .1 times or more, preferably 1.2 times or more, more preferably 1.3 times or more. The presence or absence and degree of enhanced expression can be analyzed by microarray using a three-dimensional cultured skin model.

The expression enhancer is not particularly limited as long as it contains the silk tree bark extract. The content of the silk tree bark extract (content in terms of dry mass) is not particularly limited as long as it is an effective amount for exhibiting the effect of enhancing expression, but for example, 0.00001% by mass (or w/v% ) or more, preferably 0.00005 mass% (or w/v%) or more, 0.0001 mass% (or w/v%) or more, 0.0005 mass% (or w/v%) or more, 0 .001% by mass (or w/v%) or more, 0.005% by mass (or w/v%) or more, 0.01% by mass (or w/v%) or more, or 0.05% by mass (or w /v%) or more. The content of the silk tree bark extract may be 100% by mass or less, for example, 50% by mass (or w/v%) or less, preferably 30% by mass (or w/v%) or less, 20% by mass. (or w/v%) or less, 10% by mass (or w/v%) or less, or 5% by mass (or w/v%) or less.

The expression-enhancing agent preferably contains a carrier in addition to the silk tree bark extract. The carrier is not particularly limited as long as it is physiologically or pharmaceutically acceptable. Examples include water; phosphate buffer, phosphate buffered saline, HEPES buffer, Tris-HCl buffer, boric acid Buffers such as buffers, acetate buffers, citrate buffers; capryl alcohol, lauryl alcohol, oleyl alcohol, myristyl alcohol, cetyl alcohol, cholesterol, phytosterol, cetanol, stearyl alcohol, hexyldecanol, octyldodecanol, ethanol, isopropanol, etc. higher or lower alcohols; capric acid, myristic acid, palmitic acid, stearic acid, behenic acid, lanolin fatty acid, linoleic acid, linolenic acid, lauric acid, oleic acid, isostearic acid, undecylenic acid, isononanoic acid, caproic acid, etc. Higher fatty acids or esters thereof (alkyl esters, etc.); Hydrocarbons such as liquid paraffin, squalane, microcrystalline wax, ceresin wax, paraffin wax, petrolatum; avocado oil, almond oil, fennel oil, perilla oil, olive oil, orange oil, Orange rough oil, sesame oil, cacao oil, chamomile oil, carrot oil, cucumber oil, macadamia nut oil, kukui nut oil, safflower oil, soybean oil, camellia oil, corn oil, rapeseed oil, persic oil, castor oil, cottonseed oil, peanut oil , turtle oil, mink oil, palm oil, palm kernel oil, coconut oil, grapeseed oil, Japanese wax, jojoba oil, beef tallow, beef tallow fatty acid, pork oil, egg yolk oil, hydrogenated oil; lanolin (liquid lanolin, reduced lanolin, hard lanolin, etc.), waxes such as beeswax, carnauba wax, spermaceti wax, candelilla wax, montan wax and shellac wax; silicones such as dimethylpolysiloxane and methiphenylsiloxane. These carriers may be used singly or in combination of two or more.

The expression enhancer may further contain additives. Additives are not particularly limited as long as they are physiologically or pharmaceutically acceptable, and can be appropriately selected depending on the form and mode of use. Examples include solvents, dispersants, emulsifiers, pH adjusters, agents, thickeners, preservatives, stabilizers, surfactants, excipients, binders, disintegrants, lubricants, sweeteners, flavors, colorants and the like, but are not limited to these. An additive can be used individually by 1 type or in combination of 2 or more types.

Expression enhancers may be in the form of, for example, pharmaceuticals, reagents, foods, cosmetics (including quasi-drugs), or compositions for use in these. Pharmaceuticals may be tablets, granules, powders, pills, capsules, liquids, suspensions, elixirs, emulsions, ointments, injections, patches and the like. In the case of food, beverages such as soft drinks, carbonated drinks, nutritional drinks, fruit drinks, lactic acid drinks; Frozen desserts such as ice cream, ice sherbet, and shaved ice; Noodles such as soba, udon, vermicelli, Chinese noodles, instant noodles; Candies, gums, chocolates, jellies, jams, creams, snacks, baked goods, breads, and other confectionery products; Processed marine and livestock foods, such as fish cakes, hams, and sausages; Dairy products, such as powdered milk, processed milk, and fermented milk; Margarine, mayonnaise , shortening, whipped cream, dressings and the like; seasonings such as sauces and sauces; retort pouch foods and the like. Health foods, functional foods, foods for specified health uses, foods with function claims, dietary supplements, supplements, and the like may also be used. In the case of cosmetics, basic cosmetics such as lotions, milky lotions, gels, creams, ointments, lotions, oils, packs; facial cleansers; skin cleansers; Hair cosmetics such as hair tonics, hair dyes, and hair tonics; Make-up cosmetics such as foundations, powders, powders, lipsticks, blushers, eye shadows, eyeliners and mascara; Finishing cosmetics such as nail polishes; It may be a screen or the like.

When the expression-enhancing agent is in the form of a product such as a food, it may be added to the main body of the product or its container or package, for example, an epidermal moisturizing factor or barrier function factor (in particular, an epidermal tight junction-related factor, epidermal differentiation-related factor, aquaporin). indication that it is used for enhancing the expression of epidermal moisturizing factors or barrier function factors (in particular, epidermal tight junction-related factors, epidermal differentiation-related factors, aquaporins), prevention, improvement and alleviation of symptoms associated with decreased expression, Indications to the effect that it is used for delaying progression, inhibiting progression, etc., or similar indications regarding usage patterns may be attached, and descriptions corresponding to the above indications may be included in the instructions for the product.

The expression-enhancing agent is used for the prevention or treatment (improvement, alleviation, delay of progression, progression, etc.), or for subjects with reduced expression of epidermal moisturizing factors or barrier function factors (in particular, epidermal tight junction-related factors, epidermal differentiation-related factors, and aquaporins). can. Such diseases or conditions are expressed in one selected from the group consisting of claudin 1, desmocollin 1, integrin 2, filaggrin, loricrin, keratin 1, keratin 5, keratin 10, keratin 14, and aquaporin 3. It is preferably a disease or symptom related to deterioration, and specific examples include skin aging symptoms such as rough skin and dry skin; atopic dermatitis, contact dermatitis, psoriasis, ichthyosis, psoriasis, acne, etc. skin diseases; allergic rhinitis; asthma and the like.

The method of applying the expression-enhancing agent is not particularly limited as long as the expression-enhancing effect is exhibited, and may be oral administration or parenteral administration. The method of application is preferably topical administration, preferably direct application, spreading, injection or spraying on the skin.

The present invention provides epidermal moisturizing factors or barrier function factors (in particular, epidermal tight junction-related factors, epidermal differentiation-related factors, aquaporins) to prevent or treat diseases or symptoms associated with decreased expression, or epidermal moisturizing factors. Or a composition for application to a subject with reduced expression of barrier function factors (in particular, epidermal tight junction-related factors, epidermal differentiation-related factors, aquaporins), which contains a silk tree bark extract. do. The configuration of the composition is the same as the configuration described for the expression enhancer.

EXAMPLES The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.

A three-dimensional cultured epidermis model (SkinEthic™ RHE, hereinafter referred to as “RHE”) was conditioned overnight in growth medium. After acclimation, the RHE was transferred to a 6-well plate into which 1 mL of growth medium was dispensed, and 100 μL of a test sample (Toyobo Co., Ltd. “Genemclock (trademark)”, silk tree bark extract) was applied to the stratum corneum side of the RHE. After culturing for 24 hours, the test sample was removed and washed with PBS(-).

Viability of RHE prior to RNA recovery was assessed using the Alamar Blue method. Maintenance medium containing 10% Alamar Blue reagent was dispensed into 12-well plates. RHE was transferred to this plate and cultured for 2 hours, and fluorescence intensity (Ex./Em.=544 nm/590 nm) of the culture supernatant was measured. The cell viability was calculated as Index (%) with respect to the fluorescence intensity of the test sample untreated group.

After measuring the fluorescence intensity, the RHE is removed from the transwell by punching, and stored frozen at -80°C while immersed in QIAzol (trademark) Lysis reagent (manufactured by QIAGEN). Conditions on the high concentration side where the cell viability was 90% or more were selected, and the selected RHE was disrupted using a Tissue Lyser (manufactured by QIAGEN). Purified RNA was recovered from the lysate using miRNeasy (trademark) Mini Kit (manufactured by QIAGEN). DNA microarray was performed on the collected RNA using an mRNA expression analysis chip. The obtained results were analyzed, and the results of various gene expression analyzes were expressed as a ratio with the corrected value of the control (PBS(-) applied) set to 1, and a significant difference test was performed using the Student's t-test.

The results are shown in Figures 1-3. As shown in FIGS. 1 to 3, when GenemClock™ was applied to RHE, expression of epidermal tight junction-related factors, epidermal differentiation-related factors, and aquaporins was enhanced.

Claims (5)

An agent for enhancing the expression of an epidermal moisturizing factor or a barrier function factor, containing a silk tree bark extract. The expression enhancer according to claim 1, wherein the moisturizing factor or barrier function factor is an epidermal tight junction-related factor, an epidermal differentiation-related factor, or an aquaporin. 2. The moisturizing factor or barrier function factor is selected from the group consisting of claudin 1, desmocollin 1, integrin 2, filaggrin, keratin 1, keratin 5, keratin 10, keratin 14, and loricrin, and aquaporin 3. 3. or the expression enhancer according to 2. A composition for preventing or treating a disease or condition associated with decreased expression of epidermal moisturizing factors or barrier function factors, the composition comprising an extract of Albizia bark. 5. The disease or condition according to claim 4, wherein said disease or condition is selected from the group consisting of skin aging symptoms, atopic dermatitis, contact dermatitis, psoriasis, ichthyosis, xerosis, acne, allergic rhinitis, and asthma. The described composition.

Images